QTc prolongation after regadenoson administration.
Division of Nuclear Cardiology, Hartford Hospital, Hartford, CT 06102-5037, USA.
Ankur
A
Gupta
Steven
S
Borer
Gary V
GV
Heller
D058908:Adenosine A2 Receptor Agonists / Q000009:adverse effects*; D000368:Aged; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D008297:Male; D011687:Purines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*
D058908:Adenosine A2 Receptor Agonists; D011687:Purines; D011720:Pyrazoles; C430916:regadenoson